
Robert E. Mosser
Examiner (ID: 16617, Phone: (571)272-4451 , Office: P/3714 )
| Most Active Art Unit | 3715 |
| Art Unit(s) | 3714, 3715, 3713, 3712 |
| Total Applications | 839 |
| Issued Applications | 347 |
| Pending Applications | 141 |
| Abandoned Applications | 372 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5784248
[patent_doc_number] => 20060204471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Compositions and regime/regimen for treating the adverse signs of cutaneous skin aging'
[patent_app_type] => utility
[patent_app_number] => 11/434207
[patent_app_country] => US
[patent_app_date] => 2006-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4286
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20060204471.pdf
[firstpage_image] =>[orig_patent_app_number] => 11434207
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/434207 | Compositions and regime/regimen for treating the adverse signs of cutaneous skin aging | May 15, 2006 | Abandoned |
Array
(
[id] => 5786502
[patent_doc_number] => 20060205678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Treatment of symptoms associated with irritable bowel syndrome'
[patent_app_type] => utility
[patent_app_number] => 11/436933
[patent_app_country] => US
[patent_app_date] => 2006-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5882
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205678.pdf
[firstpage_image] =>[orig_patent_app_number] => 11436933
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/436933 | Treatment of symptoms associated with irritable bowel syndrome | May 14, 2006 | Issued |
Array
(
[id] => 5546718
[patent_doc_number] => 20090156595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'Pteridines useful as HCV inhibitors and methods for the preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 11/914018
[patent_app_country] => US
[patent_app_date] => 2006-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14218
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20090156595.pdf
[firstpage_image] =>[orig_patent_app_number] => 11914018
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/914018 | Pteridines useful as HCV inhibitors and methods for the preparation thereof | May 11, 2006 | Abandoned |
Array
(
[id] => 5733621
[patent_doc_number] => 20060258738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Use of dronabinol for treatment of side effects of Hepatitis C therapy'
[patent_app_type] => utility
[patent_app_number] => 11/433378
[patent_app_country] => US
[patent_app_date] => 2006-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2373
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20060258738.pdf
[firstpage_image] =>[orig_patent_app_number] => 11433378
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/433378 | Use of dronabinol for treatment of side effects of Hepatitis C therapy | May 11, 2006 | Abandoned |
Array
(
[id] => 4613659
[patent_doc_number] => 07989625
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-02
[patent_title] => 'Thienopyridines'
[patent_app_type] => utility
[patent_app_number] => 11/915486
[patent_app_country] => US
[patent_app_date] => 2006-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18005
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 988
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/989/07989625.pdf
[firstpage_image] =>[orig_patent_app_number] => 11915486
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/915486 | Thienopyridines | May 10, 2006 | Issued |
Array
(
[id] => 5733550
[patent_doc_number] => 20060258667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Method for improving respiratory function and inhibiting muscular degeneration'
[patent_app_type] => utility
[patent_app_number] => 11/418806
[patent_app_country] => US
[patent_app_date] => 2006-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11432
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20060258667.pdf
[firstpage_image] =>[orig_patent_app_number] => 11418806
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/418806 | Method for improving respiratory function and inhibiting muscular degeneration | May 4, 2006 | Abandoned |
Array
(
[id] => 5851799
[patent_doc_number] => 20060234990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Compositions of boswellic acids derived from Boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions'
[patent_app_type] => utility
[patent_app_number] => 11/417155
[patent_app_country] => US
[patent_app_date] => 2006-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8433
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20060234990.pdf
[firstpage_image] =>[orig_patent_app_number] => 11417155
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/417155 | Compositions of boswellic acids derived from Boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions | May 3, 2006 | Abandoned |
Array
(
[id] => 5515457
[patent_doc_number] => 20090215764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Antimicrobial agents'
[patent_app_type] => utility
[patent_app_number] => 11/913380
[patent_app_country] => US
[patent_app_date] => 2006-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44648
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20090215764.pdf
[firstpage_image] =>[orig_patent_app_number] => 11913380
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/913380 | Antimicrobial agents | May 2, 2006 | Issued |
Array
(
[id] => 5705722
[patent_doc_number] => 20060194770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Methods for modulating tumor growth and metastasis'
[patent_app_type] => utility
[patent_app_number] => 11/415731
[patent_app_country] => US
[patent_app_date] => 2006-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10637
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20060194770.pdf
[firstpage_image] =>[orig_patent_app_number] => 11415731
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/415731 | Methods for modulating tumor growth and metastasis | Apr 30, 2006 | Abandoned |
Array
(
[id] => 8994551
[patent_doc_number] => 08518434
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-27
[patent_title] => 'Antiseptic spermicidal composition and means for its application'
[patent_app_type] => utility
[patent_app_number] => 11/413309
[patent_app_country] => US
[patent_app_date] => 2006-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2804
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11413309
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/413309 | Antiseptic spermicidal composition and means for its application | Apr 27, 2006 | Issued |
Array
(
[id] => 5689001
[patent_doc_number] => 20060287316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'METHOD FOR IMPROVING PHARMACOKINETICS OF PROTEASE INHIBITORS AND PROTEASE INHIBITOR PRECURSORS'
[patent_app_type] => utility
[patent_app_number] => 11/380291
[patent_app_country] => US
[patent_app_date] => 2006-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 33418
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287316.pdf
[firstpage_image] =>[orig_patent_app_number] => 11380291
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/380291 | METHOD FOR IMPROVING PHARMACOKINETICS OF PROTEASE INHIBITORS AND PROTEASE INHIBITOR PRECURSORS | Apr 25, 2006 | Abandoned |
Array
(
[id] => 9749626
[patent_doc_number] => 08841097
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-23
[patent_title] => 'Process for producing unsaturated fatty acid-containing oils'
[patent_app_type] => utility
[patent_app_number] => 11/407984
[patent_app_country] => US
[patent_app_date] => 2006-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4555
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11407984
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/407984 | Process for producing unsaturated fatty acid-containing oils | Apr 20, 2006 | Issued |
Array
(
[id] => 5672174
[patent_doc_number] => 20060177528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Formulation Of A Mixture Of Free-B-Ring Flavonoids And Flavans As A Therapeutic Agent'
[patent_app_type] => utility
[patent_app_number] => 11/279925
[patent_app_country] => US
[patent_app_date] => 2006-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 24693
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20060177528.pdf
[firstpage_image] =>[orig_patent_app_number] => 11279925
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/279925 | Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent | Apr 16, 2006 | Issued |
Array
(
[id] => 5465830
[patent_doc_number] => 20090326030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'Use of Levo-Ornidazole in the Preparation of Anti-Anaerobic Bacteria Infection Drugs'
[patent_app_type] => utility
[patent_app_number] => 11/909062
[patent_app_country] => US
[patent_app_date] => 2006-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6706
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0326/20090326030.pdf
[firstpage_image] =>[orig_patent_app_number] => 11909062
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909062 | Use of levo-ornidazole in the preparation of anti-anaerobic bacteria infection drugs | Apr 16, 2006 | Issued |
Array
(
[id] => 7693883
[patent_doc_number] => 20070015803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Methods for treating diseases through interruption of protein maturation, compounds that inhibit the function of molecular chaperones such as protein disulfide isomerases or interfere with glycosylation, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents'
[patent_app_type] => utility
[patent_app_number] => 11/402259
[patent_app_country] => US
[patent_app_date] => 2006-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3267
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20070015803.pdf
[firstpage_image] =>[orig_patent_app_number] => 11402259
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/402259 | Methods for treating diseases through interruption of protein maturation, compounds that inhibit the function of molecular chaperones such as protein disulfide isomerases or interfere with glycosylation, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents | Apr 11, 2006 | Abandoned |
Array
(
[id] => 5380238
[patent_doc_number] => 20090192077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'North-2\'deoxy -methanocarbathymidines as antiviral agents for treatment of kaposi\'s sarcoma-associated herpes virus'
[patent_app_type] => utility
[patent_app_number] => 11/918510
[patent_app_country] => US
[patent_app_date] => 2006-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 17370
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20090192077.pdf
[firstpage_image] =>[orig_patent_app_number] => 11918510
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/918510 | North-2'deoxy -methanocarbathymidines as antiviral agents for treatment of kaposi's sarcoma-associated herpes virus | Apr 10, 2006 | Abandoned |
Array
(
[id] => 5141300
[patent_doc_number] => 20070003516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Compounds, compositions and methods for the treatment of poxvirus infections'
[patent_app_type] => utility
[patent_app_number] => 11/401805
[patent_app_country] => US
[patent_app_date] => 2006-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10572
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20070003516.pdf
[firstpage_image] =>[orig_patent_app_number] => 11401805
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/401805 | Compounds, compositions and methods for the treatment of poxvirus infections | Apr 9, 2006 | Issued |
Array
(
[id] => 5479703
[patent_doc_number] => 20090202660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'Agents and Methods for Osteogenic Oxysterols Inhibition of Oxidative Stress on Osteogenic Cellular Differentiation'
[patent_app_type] => utility
[patent_app_number] => 11/918089
[patent_app_country] => US
[patent_app_date] => 2006-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 16199
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20090202660.pdf
[firstpage_image] =>[orig_patent_app_number] => 11918089
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/918089 | Agents and Methods for Osteogenic Oxysterols Inhibition of Oxidative Stress on Osteogenic Cellular Differentiation | Apr 6, 2006 | Abandoned |
Array
(
[id] => 5859872
[patent_doc_number] => 20060229293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Compositions for the treatment of hepatitis C and methods for using compositions for the treatment of hepatitis C'
[patent_app_type] => utility
[patent_app_number] => 11/398693
[patent_app_country] => US
[patent_app_date] => 2006-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3481
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20060229293.pdf
[firstpage_image] =>[orig_patent_app_number] => 11398693
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/398693 | Compositions for the treatment of hepatitis C and methods for using compositions for the treatment of hepatitis C | Apr 5, 2006 | Abandoned |
Array
(
[id] => 5922133
[patent_doc_number] => 20060240410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Retroviral protease inhibitor combinations'
[patent_app_type] => utility
[patent_app_number] => 11/396957
[patent_app_country] => US
[patent_app_date] => 2006-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14134
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20060240410.pdf
[firstpage_image] =>[orig_patent_app_number] => 11396957
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/396957 | Retroviral protease inhibitor combinations | Apr 3, 2006 | Abandoned |